Monoamine oxidase (MAO) inhibitors play a vital role in the treatment of various neurological and psychiatric disorders, such as depression, Parkinson’s disease, and Alzheimer’s disease. The identification of novel MAO inhibitors with high specificity and reduced side effects is a critical goal in drug discovery. Traditional experimental approaches, though effective, are often time-consuming and resource-intensive.This book focuses on the application of in silico screening techniques, leveraging computational tools to predict the MAO inhibitory activity of chemical compounds. By combining molecular docking, virtual screening, and structure-activity relationship (SAR) analysis, this approach offers a rapid and cost-efficient pathway to identify promising candidates for further experimental validation.The integration of in silico methodologies not only enhances the efficiency of drug discovery but also contributes to a deeper understanding of the interactions between potential inhibitors and MAO enzymes. This work aims to serve as a foundation for future research and development in this field, advancing both scientific knowledge and therapeutic innovation.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9786208424268
Quantité disponible : Plus de 20 disponibles
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9786208424268
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9786208424268
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Monoamine oxidase (MAO) inhibitors play a vital role in the treatment of various neurological and psychiatric disorders, such as depression, Parkinson's disease, and Alzheimer's disease. The identification of novel MAO inhibitors with high specificity and reduced side effects is a critical goal in drug discovery. Traditional experimental approaches, though effective, are often time-consuming and resource-intensive.This book focuses on the application of in silico screening techniques, leveraging computational tools to predict the MAO inhibitory activity of chemical compounds. By combining molecular docking, virtual screening, and structure-activity relationship (SAR) analysis, this approach offers a rapid and cost-efficient pathway to identify promising candidates for further experimental validation.The integration of in silico methodologies not only enhances the efficiency of drug discovery but also contributes to a deeper understanding of the interactions between potential inhibitors and MAO enzymes. This work aims to serve as a foundation for future research and development in this field, advancing both scientific knowledge and therapeutic innovation. 84 pp. Englisch. N° de réf. du vendeur 9786208424268
Quantité disponible : 2 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 409826472
Quantité disponible : 4 disponible(s)
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. Print on Demand. N° de réf. du vendeur 26404409207
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18404409213
Quantité disponible : 4 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. Monoamine oxidase (MAO) inhibitors play a vital role in the treatment of various neurological and psychiatric disorders, such as depression, Parkinson's disease, and Alzheimer's disease. The identification of novel MAO inhibitors with high specificity and reduced side effects is a critical goal in drug discovery. Traditional experimental approaches, though effective, are often time-consuming and resource-intensive.This book focuses on the application of in silico screening techniques, leveraging computational tools to predict the MAO inhibitory activity of chemical compounds. By combining molecular docking, virtual screening, and structure-activity relationship (SAR) analysis, this approach offers a rapid and cost-efficient pathway to identify promising candidates for further experimental validation.The integration of in silico methodologies not only enhances the efficiency of drug discovery but also contributes to a deeper understanding of the interactions between potential inhibitors and MAO enzymes. This work aims to serve as a foundation for future research and development in this field, advancing both scientific knowledge and therapeutic innovation. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9786208424268
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Monoamine oxidase (MAO) inhibitors play a vital role in the treatment of various neurological and psychiatric disorders, such as depression, Parkinson's disease, and Alzheimer's disease. The identification of novel MAO inhibitors with high specificity and reduced side effects is a critical goal in drug discovery. Traditional experimental approaches, though effective, are often time-consuming and resource-intensive.This book focuses on the application of in silico screening techniques, leveraging computational tools to predict the MAO inhibitory activity of chemical compounds. By combining molecular docking, virtual screening, and structure-activity relationship (SAR) analysis, this approach offers a rapid and cost-efficient pathway to identify promising candidates for further experimental validation.The integration of in silico methodologies not only enhances the efficiency of drug discovery but also contributes to a deeper understanding of the interactions between potential inhibitors and MAO enzymes. This work aims to serve as a foundation for future research and development in this field, advancing both scientific knowledge and therapeutic innovation.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 84 pp. Englisch. N° de réf. du vendeur 9786208424268
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Monoamine oxidase (MAO) inhibitors play a vital role in the treatment of various neurological and psychiatric disorders, such as depression, Parkinson's disease, and Alzheimer's disease. The identification of novel MAO inhibitors with high specificity and reduced side effects is a critical goal in drug discovery. Traditional experimental approaches, though effective, are often time-consuming and resource-intensive.This book focuses on the application of in silico screening techniques, leveraging computational tools to predict the MAO inhibitory activity of chemical compounds. By combining molecular docking, virtual screening, and structure-activity relationship (SAR) analysis, this approach offers a rapid and cost-efficient pathway to identify promising candidates for further experimental validation.The integration of in silico methodologies not only enhances the efficiency of drug discovery but also contributes to a deeper understanding of the interactions between potential inhibitors and MAO enzymes. This work aims to serve as a foundation for future research and development in this field, advancing both scientific knowledge and therapeutic innovation. N° de réf. du vendeur 9786208424268
Quantité disponible : 2 disponible(s)